Clinical Trial Update: Randomized Double Blind Placebo Control Study in Patients with Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 randomized double-blind placebo-controlled trial in schizophrenia and related psychotic disorders has completed; sponsor: Pakistan Institute of Living a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder Not Otherwise Specified
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Snippet

Sponsor: Pakistan Institute of Living and Learning | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED